{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:07:00Z","timestamp":1779930420447,"version":"3.53.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jnha.2026.100827","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T04:04:28Z","timestamp":1774238668000},"page":"100827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aging-related skeletal muscle loss on the incidence of chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Aryoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danbee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyun","family":"Sinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ryoun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geum-Youn","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jnha.2026.100827_bib0005","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jnha.2026.100827_bib0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.jnha.2026.100827_bib0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jnha.2026.100827_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3350\/cmh.2023.0485","article-title":"Global incidence of adverse clinical events in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"30","author":"Le","year":"2024","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"10.1016\/j.jnha.2026.100827_bib0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.jnha.2026.100827_bib0030","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.jnha.2026.100827_bib0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.17998\/jlc.2025.07.25","article-title":"Public health strategies for hepatocellular carcinoma: from risk factors to prevention and control","volume":"25","author":"Lee","year":"2025","journal-title":"J Liver Cancer"},{"issue":"4","key":"10.1016\/j.jnha.2026.100827_bib0040","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.2016121374","article-title":"Update on the burden of CKD","volume":"28","author":"Coresh","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"9887","key":"10.1016\/j.jnha.2026.100827_bib0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jnha.2026.100827_bib0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jnha.2026.100827_bib0055","article-title":"Metabolic dysfunction-associated steatotic liver disease (SLD) and alcohol-associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10-year follow-up period","author":"Mori","year":"2024","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.jnha.2026.100827_bib0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/ije\/dyl224","article-title":"Grip strength, body composition, and mortality","volume":"36","author":"Gale","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.jnha.2026.100827_bib0065","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12603-020-1390-8","article-title":"The predictive value of sarcopenia and its individual criteria for cardiovascular and all-cause mortality in suburb-dwelling older Chinese","volume":"24","author":"Han","year":"2020","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"10.1016\/j.jnha.2026.100827_bib0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.jnha.2026.100827_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101544","article-title":"Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"29","author":"Malik","year":"2024","journal-title":"Ann Hepatol"},{"issue":"9","key":"10.1016\/j.jnha.2026.100827_bib0080","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.clnu.2024.07.006","article-title":"The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"43","author":"Li","year":"2024","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.jnha.2026.100827_bib0085","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"Mozes","year":"2022","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jnha.2026.100827_bib0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3904\/kjim.2016.015","article-title":"Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia","volume":"31","author":"Kim","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.jnha.2026.100827_bib0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jnha.2026.100827_bib0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.jnha.2026.100827_bib0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13395-023-00333-z","article-title":"Restoring skeletal muscle mass as an independent determinant of liver fat deposition improvement in MAFLD","volume":"13","author":"Zhou","year":"2023","journal-title":"Skelet Muscle"},{"issue":"9","key":"10.1016\/j.jnha.2026.100827_bib0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jnha.2026.100827_bib0115","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jhep.2017.08.024","article-title":"Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: a cohort study","volume":"67","author":"Sinn","year":"2017","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jnha.2026.100827_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180951","article-title":"The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study","volume":"12","author":"Huh","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jnha.2026.100827_bib0125","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/2050640620944098","article-title":"Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease","volume":"8","author":"Kaps","year":"2020","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.jnha.2026.100827_bib0130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12877-024-04691-1","article-title":"Association between sarcopenia and new-onset chronic kidney disease among middle-aged and elder adults: findings from the China Health and Retirement Longitudinal Study","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Geriatr"},{"issue":"5","key":"10.1016\/j.jnha.2026.100827_bib0135","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1017\/S0007114523002313","article-title":"Association of sarcopenia with rapid kidney function decline and chronic kidney disease in adults with normal kidney function","volume":"131","author":"Zheng","year":"2024","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jnha.2026.100827_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108777","article-title":"Low muscle mass is associated with progression of chronic kidney disease and albuminuria - an 8-year longitudinal study in Asians with Type 2 Diabetes","volume":"174","author":"Low","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.jnha.2026.100827_bib0145","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/nu10050544","article-title":"A low-protein diet for diabetic kidney disease: its effect and molecular mechanism, an approach from animal studies","volume":"10","author":"Kitada","year":"2018","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.jnha.2026.100827_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130740","article-title":"Relationship between stage of chronic kidney disease and sarcopenia in Korean aged 40 years and older using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008-2011","volume":"10","author":"Moon","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jnha.2026.100827_bib0155","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/gerona\/glx055","article-title":"Effects of low muscle mass on albuminuria and chronic kidney disease in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS)","volume":"73","author":"Chung","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"10.1016\/j.jnha.2026.100827_bib0160","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities","volume":"39","author":"Musso","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jnha.2026.100827_bib0165","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jnha.2026.100827_bib0170","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","article-title":"Emerging liver-kidney interactions in nonalcoholic fatty liver disease","volume":"21","author":"Musso","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jnha.2026.100827_bib0175","article-title":"Sarcopenia in aging: pathogenesis, diagnosis, and emerging therapeutic frontiers","author":"Jeyaraman","year":"2025","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"10.1016\/j.jnha.2026.100827_bib0180","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3803\/EnM.2020.405","article-title":"Sarcopenia and muscle aging: a brief overview","volume":"35","author":"Dao","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"21","key":"10.1016\/j.jnha.2026.100827_bib0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113320","article-title":"Nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications","volume":"23","author":"Lonardo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.jnha.2026.100827_bib0190","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.cgh.2023.02.013","article-title":"Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) is associated with advanced fibrosis","volume":"21","author":"Harring","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jnha.2026.100827_bib0195","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/liv.14852","article-title":"Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States","volume":"41","author":"Kim","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jnha.2026.100827_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111342","article-title":"Annual changes in appendicular skeletal muscle mass and quality in adults over 50 y of age, assessed using bioelectrical impedance analysis","volume":"90","author":"Kolodziej","year":"2021","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.jnha.2026.100827_bib0205","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jnha.2026.100827_bib0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000101827","article-title":"Kidney function and sarcopenia in the United States general population: NHANES III","volume":"27","author":"Foley","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jnha.2026.100827_bib0215","article-title":"Association between chronic kidney disease and sarcopenia and emerging treatment strategies","volume":"12","author":"Li","year":"2025","journal-title":"Front Nutr"},{"issue":"12","key":"10.1016\/j.jnha.2026.100827_bib0220","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s10157-025-02752-2","article-title":"Exploring genetic association of chronic kidney disease with sarcopenia among European population: a bidirectional Mendelian randomization study","volume":"29","author":"Zhu","year":"2025","journal-title":"Clin Exp Nephrol"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770726000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770726000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:45:28Z","timestamp":1779929128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770726000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1279770726000588"],"URL":"https:\/\/doi.org\/10.1016\/j.jnha.2026.100827","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aging-related skeletal muscle loss on the incidence of chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnha.2026.100827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100827"}}